Bengaluru, March 21, 2018: Cytecare Cancer Hospital, which is committed to revolutionizing cancer care in India, has strengthened its roster with the addition of Dr. G. Rama Mohan Reddy, who will work as Consultant – Nuclear Medicine.

Dr. G. Rama Mohan Reddy is an accomplished specialist in the field of Nuclear Medicine, with over eight years of experience. Having completed his M.B.B.S. from Kurnool Medical College, Andhra Pradesh, Dr. G. Rama Mohan Reddy then went on to complete his specialization at the prestigious All India Institute of Medical Sciences, New Delhi, in the Department of Nuclear Medicine (M.D. – Nuclear Medicine).

Having acquired valuable clinical experience as a senior resident at the All India Institute of Medical Sciences, New Delhi; Dr. G. Rama Reddy went on to head the department of PET-CT and Nuclear Medicine at EKO Diagnostic Pvt. Ltd.

Dr. Reddy is extremely active in the academic medical community and has published 13 international papers on topics such as PET-CT for detecting recurrent gastric adenocarcinoma, detection of recurrent diseases in colorectal cancer, among others in reputed journals such as Nuclear Medicine Communications, International Journal of Gynecology & Obstetrics.

He is also a certified Radiological Safety Officer, with extensive training in the use of GE and SIEMENS machines to aid radio diagnosis and therapy.

Commenting on the appointment, Mr. Suresh Ramu, CEO & Co Founder, Cytecare Hospitals, said, “We are delighted to have on board Dr. G. Rama Reddy as our in-house specialist on Nuclear Medicine. PET-CT is the gold standard in the detection and diagnosis of cancer and provides accurate, anatomical landmarks to guide biopsy, surgery and even radiation treatment planning. Targeted therapy with radiopharmaceuticals has demonstrated superior clinical outcomes for cancer treatment and in Dr. Reddy, we have an expert on Nuclear Medicine who not only brings vast experience to the table, but is also ideally suited to our philosophy of ‘Fighting Cancer the Right Way’.”

Corporate Comm India(CCI Newswire)


Please enter your comment!
Please enter your name here